Know Cancer

or
forgot password

Collection of Tissue, Blood, and Other Specimens From Patients With Head and Neck Diseases to Study the Causes, Diagnosis, Prevention and Treatment of Cancers


N/A
N/A
N/A
Open (Enrolling)
Both
Head and Neck Cancers

Thank you

Trial Information

Collection of Tissue, Blood, and Other Specimens From Patients With Head and Neck Diseases to Study the Causes, Diagnosis, Prevention and Treatment of Cancers


This is a protocol to collect tissues, blood, and other specimens from patients with
malignant or nonmalignant diseases of the head and neck. Collected specimens will be used in
laboratory studies to investigate the growth, development, and transformation of normal and
abnormal cells in the future.


Inclusion Criteria:



- Patients with head and neck diseases are eligible if they have had tissue, serum,
urine, or other specimens removed or collected for diagnostic or therapeutic
purposes.

- Patients will be entered onto this protocol without preference for any racial or
ethnic group.

- Patients may have received prior chemotherapy, radiation, surgical therapy,
immunotherapy, or differentiation therapy.

- The specimen collected must be large enough to allow conventional testing necessary
for patient care, with the portion of the specimen reserved for research laboratory
analysis excised from residual tissue that would otherwise have been discarded.

Exclusion Criteria:

- Patients not giving informed consent will be excluded.

Type of Study:

Observational

Study Design:

Observational Model: Case-Only, Time Perspective: Prospective

Outcome Measure:

Collect tissues, blood, and other specimens from patients with malignant or nonmalignant diseases of the head and neck. Specimens will be used to investigate growth, development, and transformation of normal and abnormal cells in the future.

Outcome Time Frame:

36 months

Safety Issue:

No

Principal Investigator

Bhuvanesh Singh, MD

Investigator Role:

Principal Investigator

Investigator Affiliation:

Memorial Sloan-Kettering Cancer Center

Authority:

United States: Food and Drug Administration

Study ID:

04-017

NCT ID:

NCT00580203

Start Date:

February 2004

Completion Date:

December 2013

Related Keywords:

  • Head and Neck Cancers
  • HEENT cancers
  • larynx
  • thyroid
  • sarcoma
  • specimen analysis
  • Head and Neck Neoplasms

Name

Location

Memorial Sloan Kettering Cancer CenterNew York, New York  10021